Canopy Growth’s Spectrum Therapeutics Announces Expansion of Medical Cannabis Portfolio
Canopy Growth subsidiary Spectrum Therapeutics announced it will expand its medical cannabis product portfolio. The company plans to add a new lineup of prescription medicines and accelerate its expansion into the European market.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
canopygrowth.com
This content is a summary and editorial by CannabisInsight based on the above source. Copyright of the original article belongs to the respective publisher.
Original Link
https://canopygrowth.com/investors/news-releases/canopy-growth-and-spectrum-therapeutics-expand-medical-portfolio-with-new-30-and-90-pack-softgels-and-enhanced-dosing-options/